Remission of invasive thymoma due to chemotherapy. Two patients trerated with cyclophosphamide, doxorubicin, and vincristine

P. J. Loehrer, P. Bonomi, S. Goldman, S. Reddy, L. P. Faber, R. Jensik, J. R. Dainauskas

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Information regarding the effectiveness of chemotherapy in cases of invasive thymoma is limited. Two patients in whom the combination of cyclophosphamide, doxorubicin, and vincristine produced remission of invasive thymoma are described. The durations of remission were eight and seven months, respectively. In both patients, recurrence was observed at the site of bulky disease, and a secondary complete response continuing for 37 months was achieved in one of them with radiation therapy.

Original languageEnglish (US)
Pages (from-to)377-380
Number of pages4
JournalCHEST
Volume87
Issue number3
DOIs
StatePublished - Jan 1 1985

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Remission of invasive thymoma due to chemotherapy. Two patients trerated with cyclophosphamide, doxorubicin, and vincristine'. Together they form a unique fingerprint.

  • Cite this